State Street Corp Novan, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$2.95 - $4.41 $13,546 - $20,250
4,592 Added 9.17%
54,668 $215,000
Q3 2021

Nov 15, 2021
SELL
$7.48 - $10.17 $80,784 - $109,836
-10,800 Reduced 17.74%
50,076 $408,000
Q2 2021

Aug 16, 2021
BUY
$7.8 - $17.35 $474,832 - $1.06 Million
60,876 New
60,876 $612,000

About Novan, Inc.

NOVN Quotes by TradingView
  • Ticker NOVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 21,281,600
  • Market Cap $638K
  • Description
  • Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-sp...
More about NOVN
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email